642 / 1024
Local consolidative therapy versus
maintenance therapy or observation for
patients with oligometastatic NSCLC
Gomez D et al. Lancet 2016
Median PFS:
12 months
Median PFS:
4 months
|
|
642 / 1024
Local consolidative therapy versus
maintenance therapy or observation for
patients with oligometastatic NSCLC
Gomez D et al. Lancet 2016
Median PFS:
12 months
Median PFS:
4 months